Aprea Therapeutics CEO Christian Schade's 2021 pay slips 17% to $3.2M
Aprea Therapeutics reports 2021 executive compensation
By ExecPay News
Published: July 11, 2023
Aprea Therapeutics reported fiscal year 2021 executive compensation information on July 11, 2023.
In 2021, four executives at Aprea Therapeutics received on average a compensation package of $1.9M, a 27% decrease compared to previous year.
Average pay of disclosed executives at Aprea Therapeutics
Christian S. Schade, Chief Executive Officer, received $3.2M in total, which decreased by 17% compared to 2020. 45% of Schade's compensation, or $1.4M, was in option awards. Schade also received $265K in non-equity incentive plan, $530K in salary, as well as $993K in stock awards.
Eyal C. Attar, Chief Medical Officer, received a compensation package of $1.9M, which decreased by 4% compared to previous year. 34% of the compensation package, or $648K, was in stock awards.
Scott M. Coiante, Chief Financial Officer, earned $1.7M in 2021, a 6% decrease compared to previous year.
Gregory A. Korbel, Chief Operating Officer, received $667K in 2021.
Related executives
You may also like
Source: SEC filing on July 11, 2023.